Home Elastographic evaluation for fatty liver disease in north Indian children and adolescents with type 1 diabetes
Article
Licensed
Unlicensed Requires Authentication

Elastographic evaluation for fatty liver disease in north Indian children and adolescents with type 1 diabetes

  • Vinod Gupta , Devi Dayal ORCID logo EMAIL logo , Anmol Bhatia , Naresh Sachdeva , Sadhna Lal , Anju Bala and Savita Verma Attri
Published/Copyright: January 21, 2025

Abstract

Objectives

The prevalence and predisposing factors to metabolic dysfunction-associated fatty liver disease (MAFLD) in children with type 1 Diabetes (T1D) living in developing countries are unknown.

Methods

A cross-sectional study was conducted in children with T1D. The presence of liver fat and tissue stiffness were assessed by ultrasonography and shear-wave elastography (SWE), respectively. The SWE values were correlated to body mass index (BMI), glycemic control, disease duration, and gamma-glutamyl transferase (GGT). Healthy non-obese children (n=36) were recruited as controls.

Results

One hundred children with T1D were grouped (Group A-C) according to the disease duration (<5, 5–10, and >10 years, respectively). The mean diabetes duration and glycated hemoglobin were 5.9 ± 4.0 years and 8.2 ± 0.55 %, respectively. The mean SWE values were significantly higher in the patient groups compared to controls (5.07 ± 0.67, 5.27 ± 0.65, 5.16 ± 0.50, vs. 4.80 ± 0.82 kPa, p-value 0.006). The liver stiffness based on SWE showed a positive but weak relationship with BMI, diabetes duration, glycemic control, and GGT levels. A significantly higher number of children with T1D had MAFLD [9(20 %), 7(24.1 %), 7(26.9 %), vs. 1(3 %), p-value <0.001] based on ultrasonography.

Conclusions

Children with T1D showed higher liver stiffness values than controls. A weakly positive relationship of liver stiffness was observed with BMI, duration of diabetes, glycemic control, and serum GGT. Approximately one-fourth of children with diabetes showed sonographic evidence of hepatic steatosis. Larger studies are needed to ascertain the effects of obesity, diabetes duration, and metabolic control on the prevalence and progression of MAFLD in children with T1D.


Corresponding author: Devi Dayal, Endocrinology and Diabetes Unit, Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India, E-mail:

  1. Research ethics: The Institute’s Ethics Committee approved the study (IEC-INT/2022/DM-MCh-253).

  2. Informed consent: Informed consent was obtained from all individuals included in this study, or their legal guardians or wards.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: The data that support the findings of this study are available on reasonable request from the corresponding author.

References

1. Bjornstad, P, Donaghue, KC, Maahs, DM. Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment? Lancet Diabetes Endocrinol 2018;6:809–20. https://doi.org/10.1016/s2213-8587(18)30035-4.Search in Google Scholar

2. Mantovani, A, Morieri, ML, Palmisano, L, Masulli, M, Cossu, E, Baroni, MG, et al.. Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus. Cardiovasc Diabetol 2023;22:204. https://doi.org/10.1186/s12933-023-01945-x.Search in Google Scholar PubMed PubMed Central

3. Tripolino, C, Irace, C, Cutruzzolà, A, Parise, M, Barone, M, Scicchitano, C, et al.. Hepatic steatosis index is associated with type 1 diabetes complications. Diabetes Metab Syndrome Obes Targets Ther 2019;12:2405. https://doi.org/10.2147/dmso.s221969.Search in Google Scholar

4. Rinella, ME, Lazarus, JV, Ratziu, V, Francque, SM, Sanyal, AJ, Kanwal, F, et al.. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol 2024;29. https://doi.org/10.1016/j.aohep.2023.101133.Search in Google Scholar PubMed

5. Mertens, J, Van Gaal, LF, Francque, SM, De Block, C. NAFLD in type 1 diabetes: overrated or underappreciated? Ther Adv Endocrinol Metab 2021;12. https://doi.org/10.1177/20420188211055557.Search in Google Scholar PubMed PubMed Central

6. Abdallah, HR, Youness, ER, Bedeir, MM, Abouelnaga, MW, Ezzat, WM, Elhosary, Y, et al.. Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type 1 diabetes. Diabetol Metab Syndrome 2023;15:52. https://doi.org/10.1186/s13098-023-01029-6.Search in Google Scholar PubMed PubMed Central

7. Sae-Wong, J, Chaopathomkul, B, Phewplung, T, Chaijitraruch, N, Sahakitrungruang, T. The prevalence of nonalcoholic fatty liver disease and its risk factors in children and young adults with type 1 diabetes mellitus. J Pediatr 2021;230:32–7.e1. https://doi.org/10.1016/j.jpeds.2020.10.043.Search in Google Scholar PubMed

8. Tas, E, Bai, S, Mak, D, Diaz, EC, Dranoff, JA. Obesity, but not glycemic control, predicts liver steatosis in children with type 1 diabetes. J Diabet Complicat 2022;36. https://doi.org/10.1016/j.jdiacomp.2022.108341.Search in Google Scholar PubMed

9. Dayal, D, Samprathi, M, Jayaraman, D, Kohat, D, Bhalla, AK. Secular trends of body mass index in North Indian children with Type 1 diabetes do not support the Accelerator Hypothesis. Clin Endocrinol 2016;84:338–41. https://doi.org/10.1111/cen.12941.Search in Google Scholar PubMed

10. Hydes, T, Brown, E, Hamid, A, Bateman, AC, Cuthbertson, DJ. Current and emerging biomarkers and imaging modalities for nonalcoholic fatty liver disease: clinical and research applications. Clin Ther 2021;43:1505–22. https://doi.org/10.1016/j.clinthera.2021.07.012.Search in Google Scholar PubMed

11. Castera, L, Friedrich-Rust, M, Loomba, R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology 2019;156:1264–81. https://doi.org/10.1053/j.gastro.2018.12.036.Search in Google Scholar PubMed PubMed Central

12. Cassinotto, C, Boursier, J, de Lédinghen, V, Lebigot, J, Lapuyade, B, Cales, P, et al.. Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology 2016;63:1817–27. https://doi.org/10.1002/hep.28394.Search in Google Scholar PubMed

13. Younossi, ZM, Golabi, P, de Avila, L, Paik, JM, Srishord, M, Fukui, N, et al.. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 2019;71:793–801. https://doi.org/10.1016/j.jhep.2019.06.021.Search in Google Scholar PubMed

14. Sviklāne, L, Olmane, E, Dzērve, Z, Kupčs, K, Pīrāgs, V, Sokolovska, J. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes. J Gastroenterol Hepatol 2018;33:270–6. https://doi.org/10.1111/jgh.13814.Search in Google Scholar PubMed

15. Meyer, G, Dauth, N, Grimm, M, Herrmann, E, Bojunga, J, Friedrich-Rust, M. Shear wave elastography reveals a high prevalence of NAFLD-related fibrosis even in type 1 diabetes. Exp Clin Endocrinol Diabetes 2022;130:532–8. https://doi.org/10.1055/a-1666-0431.Search in Google Scholar PubMed

16. Mayer-Davis, EJ, Kahkoska, AR, Jefferies, C, Dabelea, D, Balde, N, Gong, CX, et al.. ISPAD Clinical Practice Consensus Guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018;19:7–19, https://doi.org/10.1111/pedi.12773.Search in Google Scholar PubMed PubMed Central

17. Thiagarajan, S, Shrinuvasan, S, Arun Babu, T. Screening for non-alcoholic fatty liver disease among obese and overweight children: prevalence and predictors. Indian J Gastroenterol 2022;41:63–8. https://doi.org/10.1007/s12664-021-01198-0.Search in Google Scholar PubMed

18. Agarwal, D, Bhatia, A, Saxena, AK, Dayal, D, Sodhi, KS. Role of shear wave elastography of thyroid gland in children with newly diagnosed hashimoto’s thyroiditis: preliminary study. J Ultrasound Med 2022;41:2217–25. https://doi.org/10.1002/jum.15903.Search in Google Scholar PubMed

19. Mancini, M, Salomone Megna, A, Ragucci, M, De Luca, M, Marino Marsilia, G, Nardone, G, et al.. Reproducibility of shear wave elastography (SWE) in patients with chronic liver disease. PLoS One 2017;12:e0185391. https://doi.org/10.1371/journal.pone.0185391.Search in Google Scholar PubMed PubMed Central

20. Shi, Y, Wang, Q, Sun, Y, Zhao, X, Kong, Y, Ou, X, et al.. The prevalence of lean/nonobese nonalcoholic fatty liver disease: a systematic review and meta-analysis. J Clin Gastroenterol 2020;54:378–87. https://doi.org/10.1097/mcg.0000000000001270.Search in Google Scholar PubMed

21. Friedman, SL, Neuschwander-Tetri, BA, Rinella, M, Sanyal, AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med 2018;24:908–22. https://doi.org/10.1038/s41591-018-0104-9.Search in Google Scholar PubMed PubMed Central

22. Cree-Green, M, Wiromrat, P, Stuppy, JJ, Thurston, J, Bergman, BC, Baumgartner, AD, et al.. Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance. Am J Physiol Endocrinol Metab 2019;316:E186–95. https://doi.org/10.1152/ajpendo.00258.2018.Search in Google Scholar PubMed PubMed Central

23. Jiang, S, Young, JL, Wang, K, Qian, Y, Cai, L. Diabetic-induced alterations in hepatic glucose and lipid metabolism: the role of type 1 and type 2 diabetes mellitus (Review). Mol Med Rep 2020;22:603–11. https://doi.org/10.3892/mmr.2020.11175.Search in Google Scholar PubMed PubMed Central

24. Rafaqat, S, Sattar, A, Khalid, A, Rafaqat, S. Role of liver parameters in diabetes mellitus - a narrative review. Endocr Regul 2023;57:200–20. https://doi.org/10.2478/enr-2023-0024.Search in Google Scholar PubMed

25. Salah, NY, Madkour, SS, Soliman, KS. Pancreatic shear wave elastography in children with type 1 diabetes: relation to diabetes duration, glycemic indices, fasting C-peptide and diabetic complications. Pediatr Radiol 2022;52:2348–58. https://doi.org/10.1007/s00247-022-05363-1.Search in Google Scholar PubMed PubMed Central

26. Dayal, D, Yadav, J, Kumar, R, Gupta, S, Yadav, A, Nanda, P. Glycaemic control and factors affecting it in type 1 diabetes in children: experience from a tertiary care centre in India. Pediatr Endocrinol Diabetes Metab 2022;28:281–6. https://doi.org/10.5114/pedm.2022.118326.Search in Google Scholar PubMed PubMed Central

27. Yadav, J, Kumar, R, Gupta, S, Gupta, A, Yadav, A, Dayal, D. Mauriac syndrome: a failure of parent or physician. Trop Doct 2021;51:437–40. https://doi.org/10.1177/00494755211005205.Search in Google Scholar PubMed

28. Mertens, J, De Block, C, Spinhoven, M, Driessen, A, Francque, SM, Kwanten, WJ. Hepatopathy associated with type 1 diabetes: distinguishing non-alcoholic fatty liver disease from glycogenic hepatopathy. Front Pharmacol 2021;12:768576. https://doi.org/10.3389/fphar.2021.768576.Search in Google Scholar PubMed PubMed Central

29. Rupasinghe, K, Hind, J, Hegarty, R. Updates in metabolic dysfunction-associated fatty liver disease (MAFLD) in children. J Pediatr Gastroenterol Nutr 2023;77:583–91. https://doi.org/10.1097/mpg.0000000000003919.Search in Google Scholar

30. Iorio, R, Di Dato, F, Spagnuolo, MI. From NAFLD to MAFLD to MASLD: looking for the best pediatric label. J Pediatr Gastroenterol Nutr 2023;77:575–6. https://doi.org/10.1097/mpg.0000000000003918.Search in Google Scholar PubMed

31. Mjelle, AB, Mulabecirovic, A, Havre, RF, Rosendahl, K, Juliusson, PB, Olafsdottir, E, et al.. Normal liver stiffness values in children: a comparison of three different elastography methods. J Pediatr Gastroenterol Nutr 2019;68:706–12. https://doi.org/10.1097/mpg.0000000000002320.Search in Google Scholar

32. Brunnert, L, Puasa, ID, Garten, A, Penke, M, Gaul, S, Grafe, N, et al.. Pediatric percentiles for transient elastography measurements - effects of age, sex, weight status and pubertal stage. Front Endocrinol 2022;13:1030809. https://doi.org/10.3389/fendo.2022.1030809.Search in Google Scholar PubMed PubMed Central

Received: 2024-08-08
Accepted: 2025-01-09
Published Online: 2025-01-21
Published in Print: 2025-03-26

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Thyroid surgery in pediatric age: a 10-year experience at a single center and literature review
  4. Differentiated thyroid cancer in adolescents – does extent of disease at presentation differ with age?
  5. Evaluation of iodine and selenium level and thyroid functions in patients with cystic fibrosis
  6. Interpreting positive celiac serology in children with new-onset type 1 diabetes
  7. Elastographic evaluation for fatty liver disease in north Indian children and adolescents with type 1 diabetes
  8. Diagnostic value of fasting insulin and insulin-like growth factor-1 levels in girls with central precocious puberty
  9. Clinical outcomes of switching to lonapegsomatropin from somatropin for treatment of pediatric growth hormone deficiency
  10. Development of a disease diagnostic model to predict the occurrence of central precocious puberty of female
  11. Adrenal hypoandrogenism in adolescents with premature ovarian insufficiency
  12. The clinical presentation and genetic diagnosis of Tangier disease in the pediatric age group
  13. Clinical and genetic diagnosis of first cohort of differences of sexual development in the Iranian population
  14. Short Communication
  15. Effect of a GnRH injection on kisspeptin levels in girls with suspected precocious puberty: a randomized-controlled pilot study
  16. Case Reports
  17. Coexistence of phenylketonuria and tyrosinemia type 3: challenges in the dietary management
  18. Acrodermatitis dysmetabolica: lessons from two pediatric cases
  19. Dramatic response to Evinacumab in a North Indian girl with homozygous familial hypercholesterolemia
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2024-0627/html
Scroll to top button